PHARMACEUTICAL Defence Limited has welcomed confirmation from Mundi Pharma that it will change the packaging of Targin 2.5 to differentiate it from Targin 40.
PDL raised awareness of the similarities of the packaging of the different Targin strengths in a Practice Alert issued last Oct.
THE Pharmacy Guild of Australia has formally expressed its concerns regarding the potential merger between Sigma and Chemist Warehouse (PD 07 Dec 2023) to the Australian Competition and Consumer Commission (ACCC).
FROM 01 May, pharmacists will be able to dispense Verzenio (abemaciclib) through the PBS to treat Australian patients with an invasive form of early breast cancer that is at high risk of recurring after initial treatment.
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
